These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6708397)

  • 1. [Adjuvant chemotherapy of breast cancer: persistent controversy].
    Nagel GA
    Klin Wochenschr; 1984 Feb; 62(4):145-8. PubMed ID: 6708397
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer: 8 year results.
    Senn HJ; Jungi WF; Amgwerd R; Hochuli E; Ammann J; Engelhart G; Heinz C; Wick A; Enderlin F; Creux G
    Recent Results Cancer Res; 1984; 96():90-101. PubMed ID: 6528092
    [No Abstract]   [Full Text] [Related]  

  • 3. [Neoadjuvant chemotherapy of patients with breast carcinoma].
    Jakesz R; Taucher S; Gnant M; Gebhard B; Kandioler D; Rudas M; Djavanmard M; Steger G
    Zentralbl Chir; 1998; 123 Suppl 5():147-50. PubMed ID: 10063601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short- or long-term chemotherapy for node-positive breast cancer: LMF 6 versus 18 cycles. SAKK study 27/76.
    Jungi WF; Alberto P; Brunner KW; Mermillod B; Barrelet L; Cavalli F
    Recent Results Cancer Res; 1984; 96():175-7. PubMed ID: 6396771
    [No Abstract]   [Full Text] [Related]  

  • 5. Are current worldwide studies going to answer the important questions remaining in adjuvant chemotherapy of breast cancer?
    Brunner KW
    Recent Results Cancer Res; 1984; 96():224-36. PubMed ID: 6396778
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical trials referral resource. Adjuvant therapy of breast cancer.
    Cheson BD
    Oncology (Williston Park); 1989 Jun; 3(6):70-1, 74-5, 78. PubMed ID: 2534915
    [No Abstract]   [Full Text] [Related]  

  • 7. Contribution of prognostic factors to adjuvant chemotherapy in breast cancer.
    Bonadonna G; Valagussa P
    Recent Results Cancer Res; 1984; 96():34-45. PubMed ID: 6528090
    [No Abstract]   [Full Text] [Related]  

  • 8. [Principles of adjuvant drug therapy in breast cancer].
    Castiglione M; Schnürch HG; Bender HG; Goldhirsch A
    Gynakologe; 1994 Apr; 27(2):49-63. PubMed ID: 8039743
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant chemotherapy of breast cancer: hope--reality--hazard?
    Vorherr H
    Klin Wochenschr; 1984 Feb; 62(4):149-61. PubMed ID: 6708398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [10 years' therapy of breast cancer].
    Schreml W
    Onkologie; 1986 Oct; 9 Suppl 2():49-56. PubMed ID: 3534674
    [No Abstract]   [Full Text] [Related]  

  • 11. Weight gain in patients receiving adjuvant chemotherapy for carcinoma of the breast.
    Huntington MO
    Cancer; 1985 Aug; 56(3):472-4. PubMed ID: 3839160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodal therapy for stage-II breast cancer.
    Baum M
    Lancet; 1977 Sep; 2(8037):564. PubMed ID: 95775
    [No Abstract]   [Full Text] [Related]  

  • 13. Review: scientific basis of adjuvant chemotherapy in breast cancer.
    Griswold DP
    Recent Results Cancer Res; 1984; 96():46-7. PubMed ID: 6528091
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjuvant systemic therapy of breast cancer.
    Lippman ME
    Important Adv Oncol; 1985; ():254-72. PubMed ID: 3916744
    [No Abstract]   [Full Text] [Related]  

  • 15. When is adjuvant treatment of stage IIIA breast cancer recommended?
    Siemers R
    Oncology (Williston Park); 1987 Dec; 1(10):39. PubMed ID: 3275339
    [No Abstract]   [Full Text] [Related]  

  • 16. [Early-stage breast cancer - strategies for adjuvant systemic therapy].
    Görner M; Just M; Gerull S
    Handchir Mikrochir Plast Chir; 2008 Aug; 40(4):230-8. PubMed ID: 18716990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic update on cancer of the breast].
    Awada A; Leo AD; Piccart MJ
    Bull Cancer; 2000 Jan; 87(1):49-62. PubMed ID: 10673632
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
    Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast.
    Botti C; Vici P; Lopez M; Scinto AF; Cognetti F; Cavaliere R
    J Am Coll Surg; 1995 Sep; 181(3):202-8. PubMed ID: 7670678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A Case of Locally Advanced and Metastatic Breast Cancer Treated with Preoperative Bevacizumab Combination Chemotherapy That Attained Local Control].
    Watanabe N; Furukawa J; Minoji T; Tamai K; Kitahara T; Yamamura N; Okamura S; Fukuchi N; Ebisui C; Yokouchi H; Kinuta M
    Gan To Kagaku Ryoho; 2018 Jul; 45(7):1097-1099. PubMed ID: 30042280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.